Dallas, TX
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CANCER PREVENTION INITIATIVE INC, founded in 2015, is a small nonprofit in the Medical Research sector that reported $779K in total revenue in fiscal year 2025. Revenue fell 53% from the prior year — a significant decline worth monitoring. Expenses of $857K exceeded revenue, resulting in a 10% operating deficit.
Cancer Prevention Initiative, Inc. (CPI) is a nonprofit corporation whose mission is to accelerate the discovery and development of new medicines that prevent cancer. CPI uses its research, medical and pharmaceutical expertise to invest in first-rate science that will discover new medical methods for preventing cancer. Our strategy is to support research on prevention of inherited cancers as a path towards elimination of all cancers. CPI acts as a facilitator to ensure that good ideas can find sufficient funding to turn them into therapeutic solutions such as drugs or vaccines to prevent cancer. CPI provides financial support, guidance and expertise throughout the research and development process to help researchers use the resources (donations) for the highest possible impact.
In 2025, Cancer Prevention Initiative (CPI) supported five active projects studying therapeutic prevention of inherited cancer. Four of the projects study BRCA1/2 mutated cancers and one project...
In 2025, Cancer Prevention Initiative (CPI) supported five active projects studying therapeutic prevention of inherited cancer. Four of the projects study BRCA1/2 mutated cancers and one project studies Lynch Syndrome. Two of the projects, one at Cleveland Clinic and one at Dana-Farber, are developing immunoprevention strategies to combat BRCA mutant breast cancer. Another immunoprevention project at MD Anderson is developing vaccines to prevent Lynch syndrome-associated colorectal cancer. The project at Harvard/Beth Israel Deaconess Medical center is identifying risk factors in the fallopian tube that gives rise to ovarian cancer in BRCA1 mutation carriers. This work would help develop tests and assays for early detection and risk assessment of ovarian cancer. At Memorial Sloan Kettering Cancer Center, CPI supports a project to prevent Loss of Heterozygosity (LoH) of BRCA genes, a major driver in cancer initiation, and thereby prevent the development of cancer.
Education and engagement programs: As we move closer to our goal of eradicating all cancers through preventative medicines, we believe that raising awareness about inherited cancer syndromes will...
Education and engagement programs: As we move closer to our goal of eradicating all cancers through preventative medicines, we believe that raising awareness about inherited cancer syndromes will inspire more individuals to take proactive, life-saving preventive measures. One of the goals is to enhance the scientific reach of the organization and raise awareness on cancer prevention to a broader audience of patients, advocates and donors. Updates on scientific and medical research advances, recent clinical trials, and interviews with experts in cancer prevention are published on web-based platforms.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $778,663 | $1,673,681 | -0.5% |
| Expenses | $856,539 | $703,827 | +0.2% |
| Net Income | $-77,876 | $969,854 | -1.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Theodora Ross | President & Chief Scientific Officer; Trustee | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Howard Janzen | Board Chair; Secretary; Trustee | 5 |
Officer
Director
|
$0 | $0 | $0 |
| Jan Livingston-Mokhtari | Trustee | 1 |
Director
|
$0 | $0 | $0 |
| Douglas Hager | Trustee, Sr. Vice President, Project Management and Operations | 10 |
Director
|
$0 | $0 | $0 |
| Joi Morris | Treasurer, Trustee | 6.00 |
Officer
Director
|
$0 | $0 | $0 |
| Kirk Patrick | Secretary, Trustee | 0.5 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $778,663 | $856,539 | $1,927,394 | $-77,876 |
| 2024 | No data | No data | No data | No data |
| 2023 | $49,585 | $74,394 | $821,212 | $-24,809 |
| 2022 | $257,068 | $18,418 | $1,056,196 | $238,650 |
| 2021 | $151 | $308,042 | $962,671 | $-307,891 |
| 2020 | $481,790 | $572,883 | $1,546,694 | $-91,093 |
| 2018 | $1,224,228 | $561,608 | $2,632,592 | $662,620 |
Compare CANCER PREVENTION INITIATIVE INC with other nonprofits in Texas and across the country.